Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Maxime Halliez"'
Autor:
Beatrice Mahe, Cécile Vigneau, Philippe Moreau, Olivier Decaux, Christian Agard, Patrick Jego, Bernard Grosbois, Mohamed Hamidou, Thomas Dejoie, F. Perrin, Maxime Halliez, Benoit Tessoulin, Thierry Lamy, Fadi Fakhouri, Lucienne Guenet, Antoine Néel
Publikováno v:
American Journal of Hematology. 89:156-161
The aim of this study is to investigate long-term outcome of symptomatic type 1 cryoglobulinemia (CG) and its determinants. Retrospective cohort study was conducted in two French University Hospitals. Patients with type 1 CG were identified using lab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff911766febc3a5a797f05c1f7437672
https://doi.org/10.1002/ajh.23608
https://doi.org/10.1002/ajh.23608
Autor:
Marc Trossaert, Nelly Robillard, Marie-Christine Béné, Marianne Sigaud, Maxime Halliez, Marc Fouassier, Catherine Ternisien
Publikováno v:
British journal of haematology. 171(2)
Keywords: Scott syndrome; phospholipid flip–flop; phosphatidyl serine; flow cytometry; bleeding disorders
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a98a24d976a2392b835c33b480bbe7
https://pubmed.ncbi.nlm.nih.gov/25823976
https://pubmed.ncbi.nlm.nih.gov/25823976
Autor:
Charlotte Kervoëlen, Patricia Gomez-Bougie, Philippe Moreau, Catherine Pellat-Deceunynck, Catherine Godon, Martine Amiot, Sophie Maïga, Maxime Halliez
Publikováno v:
Cancer Biology and Therapy
Cancer Biology and Therapy, Taylor & Francis, 2015, 16 (1), pp.60-5. ⟨10.4161/15384047.2014.986997⟩
Cancer Biology and Therapy, 2015, 16 (1), pp.60-5. ⟨10.4161/15384047.2014.986997⟩
Cancer Biology & Therapy
Cancer Biology and Therapy, Taylor & Francis, 2015, 16 (1), pp.60-5. ⟨10.4161/15384047.2014.986997⟩
Cancer Biology and Therapy, 2015, 16 (1), pp.60-5. ⟨10.4161/15384047.2014.986997⟩
Cancer Biology & Therapy
International audience; Multiple myeloma (MM), a plasma cell malignancy, remains incurable despite the development of new therapies. Curcumin anti-tumor effects were previously characterized in multiple myeloma, however only few MM cell lines were in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0595990025d8e6a537eed84fe6fbb36
https://www.hal.inserm.fr/inserm-02534388
https://www.hal.inserm.fr/inserm-02534388
Autor:
Audrey Ménard, Cyrille Touzeau, Anne Lok, Martine Amiot, Catherine Pellat-Deceunynck, Sophie Maiga, Florence Magrangeas, Stephane Minvielle, Nicolas Blin, Beatrice Mahe, Viviane Dubruille, Benoit Tessoulin, Maxime Halliez, Soraya Wuillème, Nelly Robillard, Philippe Moreau, Hervé Maisonneuve, Henry Jardel, Marie C. Bene, Laurence Lodé
Publikováno v:
Blood. 122:3107-3107
Cereblon (CRBN) was recently identified as a protein binding immunomodulatory drugs (IMiDs) (Ito et al., 2010, Lopez-Girona et al., 2011) essential for the activity of thalidomide, lenalidomide and pomalidomide in patients suffering from multiple mye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b493e376628212b92f6f711b20ac03f
https://doi.org/10.1182/blood.v122.21.3107.3107
https://doi.org/10.1182/blood.v122.21.3107.3107
Autor:
Philippe Moreau, Patricia Gomez-Bougie, Sophie Maïga, Steven Le Gouill, Catherine Pellat-Deceunynck, Cyrille Touzeau, Martine Amiot, Maxime Halliez, Bene, PharmSciD, Marie-Christine
Publikováno v:
Blood. 122:1921-1921
Multiple myeloma (MM) is a heterogeneous but incurable plasma cell malignancy which still requires new therapeutic approaches. Several molecular subsets of MM have been defined based on genetic and chromosomal aberrations. Briefly, t(4;14) or t(14;16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::786cf759d93c8f075ad406e82d3ffbf0
https://doi.org/10.1182/blood.v122.21.1921.1921
https://doi.org/10.1182/blood.v122.21.1921.1921
Autor:
Marie C. Béné, Marion Eveillard, Pascaline Talmant, Olivier Theisen, Laurence Lodé, Soraya Wuilleme, Philippe Moreau, Nicolas Blin, Cécile Girard, Alexander Kohlmann, François Subiger, Maxime Halliez, Audrey Ménard, Sophie Sadot-Lebouvier, Steven Richebourg, Catherine Godon, Odile Luycx, Pascal Godmer, Bruno Villemagne, Yannick Le Bris, Marion Loirat, Nadine Morineau, Jacques Delaunay
Publikováno v:
Blood. 122:520-520
Landscape analyses of mutational patterns have shown that virtually all myelodysplastic syndromes (MDS) harbor somatic mutations in >80% of cases. These molecular alterations provide useful clonality markers with a potential for early diagnosis of MD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd31f0cfc9e9281285f62ee6e7c0cd07
https://doi.org/10.1182/blood.v122.21.520.520
https://doi.org/10.1182/blood.v122.21.520.520
Autor:
Martine Amiot, Patricia Gomez-Bougie, Sophie Maïga, Catherine Pellat-Deceunynck, Maxime Halliez, Cyrille Touzeau, Steven Le Gouill
Publikováno v:
Molecular Cancer Therapeutics. 12:C48-C48
Multiple myeloma (MM) is a heterogeneous but incurable plasma cell malignancy which still requires new therapeutic approaches. Several molecular subsets of MM have been defined based on genetic and chromosomal aberrations. Briefly, t(4;14) or t(14;16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::841585b448f589a5b80ab342566597c3
https://doi.org/10.1158/1535-7163.targ-13-c48
https://doi.org/10.1158/1535-7163.targ-13-c48